SEC Form 4 · accession 0001179110-15-007535
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dorothy E Puhy
Director
Period of report
May 7, 2015
Accepted (ET)
May 11, 2015 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF1,F4 | May 7, 2015 | S | 2,611 | $69.9971 | D | 70,617 | D | |
| Common Stock, $0.01 par valueF1,F5 | May 7, 2015 | S | 403 | $70.8091 | D | 70,214 | D | |
| Common Stock, $0.01 par valueF1,F6 | May 7, 2015 | S | 260 | $71.8516 | D | 69,954 | D | |
| Common Stock, $0.01 par valueF1,F7 | May 7, 2015 | S | 128 | $73.0029 | D | 69,826 | D | |
| Common Stock, $0.01 par valueF1,F8 | May 7, 2015 | S | 22 | $73.7763 | D | 69,804 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F9 | $13.21 | holding | — | — | — | Aug 8, 2007 | Aug 9, 2016 | Common Stock | 8,000 | 8,000 | D |
| Stock option (right to buy)F2,F9 | $12.69 | holding | — | — | — | Aug 13, 2008 | Aug 8, 2017 | Common Stock | 8,000 | 8,000 | D |
| Stock Option (right to buy)F3,F9 | $18.63 | holding | — | — | — | Aug 12, 2009 | Aug 13, 2018 | Common Stock | 13,500 | 13,500 | D |
| Stock Option (right to buy)F3,F9 | $7.67 | holding | — | — | — | Aug 11, 2010 | Aug 12, 2019 | Common Stock | 13,500 | 13,500 | D |
| Stock Option (right to buy)F3,F9 | $9.99 | holding | — | — | — | Aug 10, 2011 | Aug 11, 2020 | Common Stock | 13,500 | 13,500 | D |
Explanation of responses
- F1Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- F2Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- F3Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F4This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.5000 and $70.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F5This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.5000 and $71.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F6This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.5200 and $72.3900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F7This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.5300 and $73.4100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F8This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $73.5300 and $73.9000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F9This option becomes exerciseable in full on the date set forth in Table II, Column 6.